Luye Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Explore ways to resolve three of the key challenges in the field of mRNA-based therapies

Korean and Chinese business leaders have met in Seoul to renew manuals on keeping the bilateral alliance up to date, according to the Korea Chamber of Commerce and Industry (KCCI), Wednesday.

Templewater is close to signing a deal that will give it a majority stake in the oncology and cardiology units of Luye Medical in Singapore.

Share this article Share this article BOSTON, May 13, 2021 /PRNewswire/ -- The Boston R&D Center and GeneLeap Biotech, two subsidiaries of Luye Life Sciences Group, took part in the 24 th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, presenting the progress of four of the company's latest preclinical developments in gene and cell therapy to the global biological community. ASGCT is one of the world's most influential academic conferences in the area of gene and cell therapy. More than 3,500 scholars, clinical investigators, physicians and other professionals attend the me...

GeneLeap Announces Novel GalNAc Synthesis and Evaluation in Mice as Antisense Oligonucleotide Conjugates at ACS 2021 News provided by Share this article Share this article BOSTON, April 25, 2021 /PRNewswire/ -- GeneLeap Biotech, a subsidiary of Luye Life Sciences specializing in the development of nucleic acid therapeutics, presented an e-poster entitled ' Design and synthesis of novel GalNAc linker moieties, conjugation to antisense oligonucleotides and evaluation in mice' at the Spring Meeting of the American Chemical Society (ACS) 2021. The study reported new synthetic methodologies for th...